| Improved Drug Susceptibility Testing (DST) for Tuberculosis (R01 Clinical Trial Not Allowed)- RFA-AI-22-016 |
R01
|
March 02, 2022 |
July 09, 2022 |
| Innovation for HIV Vaccine Discovery (R01 Clinical Trial Not Allowed)- PAR-20-158 |
R01
|
March 31, 2020 |
July 29, 2022 |
| Partnerships for the Development of Novel Therapeutics to Combat Select Antibiotic Resistant Bacteria and Fungi (R01 Clinical Trial Not Allowed)- RFA-AI-22-028 |
R01
|
April 05, 2022 |
July 30, 2022 |
| Development of HIV Broadly Neutralizing Antibody Susceptibility Assays (R61/R33 Clinical Trial Not Allowed)- RFA-AI-22-022 |
R61/R33
|
March 10, 2022 |
August 04, 2022 |
| Enhancing HIV Reservoir Susceptibility to Elimination (R01 Clinical Trial Not Allowed)- RFA-AI-22-025 |
R01
|
March 29, 2022 |
August 04, 2022 |
| International Research in Infectious Diseases (R01 Clinical Trial Not Allowed)- PAR-20-108 |
R01
|
February 04, 2020 |
August 20, 2022 |
| Getting To Zero—Understanding HIV Viral Suppression and Transmission in the United States (R01, Clinical Trial Optional)- PAR-20-036 |
R01
|
October 24, 2019 |
September 08, 2022 |
| Understanding the Clinical History of Bacterial Sexually Transmitted Infections (STI) to Accelerate Diagnostic and Vaccine Development (R01 Clinical Trial Not Allowed)- RFA-AI-22-034 |
R01
|
May 12, 2022 |
September 13, 2022 |
| Partnerships for Development of Vaccines Against Select Enteric Pathogens (R01 Clinical Trial Not Allowed)- RFA-AI-22-037 |
R01
|
May 10, 2022 |
September 15, 2022 |
| Notice of Special Interest (NOSI)—Advancing Research for Tickborne Diseases (TBDs)- NOT-AI-20-005 |
R01, R15, R41/R42, R43/R44
|
November 12, 2019 |
January 08, 2023 |
| Notice of Special Interest (NOSI)—Advancing Development of Rapid Point-of-Care Hepatitis C Virus Diagnostics- NOT-AI-20-013 |
R01, R21, R41/R42, R43/R44
|
December 17, 2019 |
January 08, 2023 |
| Notice of Special Interest (NOSI)—Mechanisms of Mycobacterial-Induced Immunity in HIV-Infected and/or Uninfected Individuals To Inform Innovative Tuberculosis Vaccine Design- NOT-AI-20-071 |
R01, R21
|
September 10, 2020 |
January 08, 2023 |
| Notice of Special Interest (NOSI)—Complement in Basic Immunology (CIBI)- NOT-AI-21-008 |
R01, R21
|
February 04, 2021 |
January 08, 2023 |
| Notice of Special Interest (NOSI)—Research to Address Vaccine Hesitancy, Uptake, and Implementation among Populations that Experience Health Disparities- NOT-MD-22-006 |
R01
|
December 21, 2021 |
January 08, 2023 |
| Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required)- PAR-20-139 |
R01
|
March 13, 2020 |
January 14, 2023 |
| Research on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) (R01 Clinical Trials Not Allowed)- PAR-20-165 |
R01
|
April 13, 2020 |
March 06, 2023 |
| New Technologies for the In vivo Delivery of Gene Therapeutics for an HIV Cure (R01 Clinical Trial Not Allowed)- RFA-AI-20-076 |
R01
|
October 20, 2020 |
March 18, 2023 |
| Detection of HIV for Self-Testing (R61/R33 Clinical Trial Not Allowed)- PAR-21-070 |
R61/R33
|
November 13, 2020 |
March 18, 2023 |
| Notice of Special Interest (NOSI)—Research on the Health of Sexual and Gender Minority (SGM) Populations- NOT-MD-19-001 |
Multiple |
March 13, 2019 |
May 08, 2023 |
| Research on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) (R21 Clinical Trials Not Allowed)- PAR-20-168 |
R21
|
April 13, 2020 |
May 08, 2023 |
| NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)- PA-20-185 |
R01
|
May 05, 2020 |
May 08, 2023 |
| Research Project Grant (Parent R01 Clinical Trial Required)- PA-20-183 |
R01
|
May 05, 2020 |
May 08, 2023 |
| NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed)- PA-20-200 |
R03
|
May 07, 2020 |
May 08, 2023 |
| NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed)- PA-20-195 |
R21
|
May 07, 2020 |
May 08, 2023 |
| NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Required)- PA-20-194 |
R21
|
May 07, 2020 |
May 08, 2023 |
